GeneDx to Participate in Fall Investor Conferences
GeneDx to Participate in Fall Investor Conferences
STAMFORD, Conn.--(BUSINESS WIRE)--Aug. 12, 2024--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall:
康涅狄格州斯坦福--(BUSINESS WIRE)--2024年8月12日--GeneDx(納斯達克:WGS)是通過基因組洞見提供改善健康結果的領先者,今天宣佈公司管理層將參加今年秋季的投資者會議:
-
UBS Genomic Medicine Summit – August 13-14, 2024
Dana Point, California
Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT -
Morgan Stanley Healthcare Conference - September 4-6, 2024
New York, New York -
Wells Fargo Healthcare Conference - September 4-6, 2024
Boston, Massachusetts
Fireside chat on Thursday, September 5 at 8:45 a.m. ET -
Jefferies London Healthcare Conference - November 19-21, 2024
London, England
- UBS基因醫學峯會-2024年8月13日至14日
位於加利福尼亞州的達納角
遺傳測試的未來 - 嬰兒和更多委員會將於8月14日星期三上午8:00(PT)舉行 - 摩根士丹利醫療保健大會-2024年9月4日至6日
紐約州紐約市 - 富國銀行醫療保健大會-2024年9月4日至6日
馬薩諸塞州波士頓
第二天-9月5日(星期四)上午8:45(ET)的主題演講 - 傑富瑞倫敦醫療保健大會-2024年11月19日至21日
倫敦,英格蘭
Live and archived webcasts of select presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
GeneDx投資者關係網站的「活動」部分將提供所選演示文稿的現場和存檔網絡廣播。 ir.genedx.com/news-events/events。
About GeneDx
關於GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.
在GeneDx (納斯達克:WGS) ,我們認爲每個人都應該得到個性化的、有針對性的醫療保健——而這一切都始於基因診斷。受世界上最大的罕見病數據集之一的推動,我們行業領先的外顯子組和基因組測試將複雜的基因組數據轉化爲臨床答案,從而解鎖個性化健康計劃,加速藥物發現,並提高衛生系統效率。這一切都始於一次簡單的測試。欲了解更多信息,請訪問genedx.com,並通過 LinkedIn 、X、Facebook和Instagram與我們聯繫。
View source version on businesswire.com:
請查看商業線(businesswire.com)的源版本。
Investor Relations Contact:
investors@GeneDx.com
Media Contact:
press@GeneDx.com
投資者關係聯繫人:
investors@GeneDx.com
媒體聯繫人:
press@GeneDx.com
Source: GeneDx
來源:GeneDx